Nothing we didn't know but I still like seeing these kinds of words .....
..... Imugene managing director and CEO Leslie Chong said: “There is strong medical investigator interest following the good results seen in the recently completed Phase Ib trial, where 11 out of 14 evaluable patients showed clinically meaningful responses.
being said about my retirement fund!
https://www.drugdevelopment-technology.com/news/imugene-cancer-vaccine-phase-ii/
FYI..
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.8¢ | 3.7¢ | $270.7K | 7.251M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 949810 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 2277658 | 11 |
View Market Depth
| Last trade - 16.10pm 26/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
